search
Back to results

Toric IOL vs Non-toric IOL With LRI for Corneal Astigmatism

Primary Purpose

Corneal Astigmatism

Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Toric intraocular MX60T lens
Standard MX60 plus corneal incisions
Sponsored by
Ashford and St. Peter's Hospitals NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Corneal Astigmatism

Eligibility Criteria

21 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Bilateral cataract.
  • Age 21 and older.
  • Written informed consent to sequential bilateral surgery and participation in the study.
  • Preoperative pupil size greater than or equal to 5.0 mm in the study eye.
  • IOL power as predicted by biometry ranging from 6.0 D to 30.0 D in both eyes.
  • Regular corneal astigmatism according to Orbscan topography.
  • Postoperative corneal astigmatism between 0.90 D and 1.40 D in both eyes, as predicted by the Bausch + Lomb Toric Calculator (https://envista.toriccalculator.com).

Exclusion Criteria:

  • Ocular comorbidity (corneal scars, amblyopia, retina, or optic nerve disease) that may reduce postoperative CDVA
  • Reduced zonular or capsular stability (e.g. Marfan syndrome, previous eye trauma)
  • Irregular corneal astigmatism on Orbscan topography

Sites / Locations

  • Dr Isaac JohnRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Toric intraocular MX60T lens

Standard MX60 plus corneal incisions

Arm Description

one eye will receive toric MX60T lens

the other eye will receive standard MX60 lens with corneal incisions

Outcomes

Primary Outcome Measures

Astigmatism reduction effect of toric intraocular lens (IOL) versus non-toric IOL with limbal relaxing incisions.
Astigmatism reduction will be evaluated with optical biometry, corneal topography
Astigmatism reduction effect of toric intraocular lens (IOL) versus non-toric IOL
Astigmatism reduction will be evaluated with manifest refraction, autorefraction

Secondary Outcome Measures

Unaided visual acuity after toric intraocular lens (IOL) versus non-toric IOL with limbal relaxing incisions.
Measurement of uncorrected visual acuity, monocular and binocular, will be done using a back-lit EDTRS chart placed at 4m. Although these assessments appear to have different units of measurements, but all the measurements will be in the same units of measure.
Best-spectacle corrected visual acuity after toric intraocular lens (IOL) versus non-toric IOL with limbal relaxing incisions.
Measurement of best-spectacle corrected visual acuity, monocular and binocular, will be done using a back-lit EDTRS chart placed at 4m.
Quality of Vision
Quality of Vision will be evaluated with the QoV (Quality of Vision) questionnaire score. It is a validated, Rasch-adjusted questionnaire in which patients are asked to rate 10 dysphotopsia items illustrated by standard photographs, scoring each item (0, 1, 2, 3) in relation to how frequent, severe, and bothersome their symptoms are (30 items in total).
Visual disability
Visual disability will be evaluated with the Catquest 9-SF cataract visual disability questionnaire. It is a Rasch-adjusted cataract visual disability questionnaire that asks patients to rate difficulty with a range of vision-related daily activities.
Overall satisfaction
Overall satisfaction will be evaluated with vision rating questionnaire. It will be obtained by asking patients to rate whether they were very satisfied, satisfied, neither satisfied nor unsatisfied, unsatisfied, or very unsatisfied.
Dysphotopsia
Dysphotopsia will be evaluated with the Dysphotopsia questionnaire. They are 4 questions regarding dysphotopsia symptoms: "Since your surgery, have you noticed any" halo, glare or dazzle, unwanted images, or shadows? Patients were asked to respond by indicating whether they had not experienced these symptoms at all ("none") or found them "barely noticeable," "annoying," or "debilitating."

Full Information

First Posted
February 2, 2018
Last Updated
August 14, 2018
Sponsor
Ashford and St. Peter's Hospitals NHS Trust
Collaborators
Bausch & Lomb Incorporated
search

1. Study Identification

Unique Protocol Identification Number
NCT03633851
Brief Title
Toric IOL vs Non-toric IOL With LRI for Corneal Astigmatism
Official Title
Toric Intraocular Lens (IOL) Implantation Compared to Incisional Surgery to Correct Corneal Astigmatism as Part of Cataract Surgery - A Randomised Controlled Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Unknown status
Study Start Date
October 3, 2017 (Actual)
Primary Completion Date
August 2019 (Anticipated)
Study Completion Date
August 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ashford and St. Peter's Hospitals NHS Trust
Collaborators
Bausch & Lomb Incorporated

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the study is to compare the astigmatism reducing effect of a toric intraocular lens (IOL) (model MX60T - Bausch & Lomb) with that of limbal relaxing incisional surgery combined with a non toric IOL (model MX60 - Bausch & Lomb) in patients with corneal astigmatism between 1.0 and 1.5 diopters and also the effect of cylinder reduction on patient's quality of vision.
Detailed Description
This is a randomised controlled trial with intra-patient comparison (bilateral study) in which study patients will be randomized by a medical statistician to the implantation of the toric intraocular lens (IOL) (model MX60T, Bausch & Lomb) in one eye and the non-toric IOL model MX60 plus LRI in the fellow eye. During pre-operative examination, the patient will undergo: An ophthalmic examination including slit lamp biomicroscopy and retinal examination; Uncorrected and best-corrected visual acuity (UCVA and BCVA): monocular and binocular; Optical biometry with IOLMaster (Carl Zeiss Meditec); Orbscan corneal topography (Bausch and Lomb Orbscan IIz Corneal Analysis System); Quality of Vision (QoV) questionnaire score). It is a validated, Rasch-adjusted questionnaire in which patients are asked to rate 10 dysphotopsia items illustrated by standard photographs, scoring each item (0, 1, 2, 3) in relation to how frequent, severe, and bothersome their symptoms are (30 items in total). Catquest 9-SF cataract visual disability questionnaire. It is a Rasch-adjusted cataract visual disability questionnaire that asks patients to rate difficulty with a range of vision-related daily activities. The appropriate cylinder power of the MX60T toric-IOL as well of its axis of implantation will be calculated with the calculator provided by the manufacturer Bausch + Lomb (https://trulign.toriccalculator.com). Subsequently, the patient will undergo cataract surgery with IOL implantation under local anaesthesia. The temporal self-sealing incision, injection of viscoelastic substance, capsulorhexis, phacoemulsification, irrigation/aspiration of cortical material and injection of viscoelastic substance into the capsular bag will be performed as standard procedure. According to randomisation, each patient will receive the implantation of the MX60T toric-IOL in one eye and the MX60 non-toric IOL combined with limbal relaxing incisions (LRI) in the fellow eye. The eye that will receive the toric-IOL will have the horizontal meridian marked preoperatively at the limbus in the sitting position with a blue marking pen and insulin syringe. The IOL will be implanted via injector into the capsular bag using the manufacturers' recommended IOL loading and injection technique. The toric-IOL will be rotated in the capsular bag so that the axis markers on the IOL will be aligned to the limbal markings (planned axis). Then, the viscoelastic substance will be aspirated thoroughly from the eye. Final refinement of axis position of the IOL will be undertaken after removal of viscoelastic material from the capsular bag to ensure that irrigation/aspiration of viscoelastic does not move the lens off axis. The fellow eye will receive a temporal or an on-axis incision with limbal relaxing incision with a 600µm single-use steel blade combined with the MX60 non-toric IOL (http://www.lricalculator.com). The interval between the first and second eye surgery will be recorded. The location and length of the LRIs will be made after calculation according to the Donnenfeld nomogram (www.lricalculator.com). After one hour postoperatively, a photo of the toric-IOL in retroillumination will be taken to evaluate if IOL is on axis. At six months and twelve months after the surgery performed in the second eye, patients will undergo assessement of: autorefraction; unaided and best-spectacle corrected visual acuity (monocular and binocular), optical biometry; corneal topography; photo of the toric-IOL in retroillumination (to evaluate if IOL is on axis); Catquest 9-SF cataract visual disability questionnaire; Quality of Vision (QoV) questionnaire score; Overall satisfaction with vision rating questionnaire (only at 6 months and 12 months). It will be obtained by asking patients to rate whether they were very satisfied, satisfied, neither satisfied nor unsatisfied, unsatisfied, or very unsatisfied. Dysphotopsia questionnaire. They are 4 questions regarding dysphotopsia symptoms: "Since your surgery, have you noticed any" halo, glare or dazzle, unwanted images, or shadows? Patients were asked to respond by indicating whether they had not experienced these symptoms at all ("none") or found them "barely noticeable," "annoying," or "debilitating." Statistical analysis will be performed using SPSS for Macintosh software (version 20.0, International Business Machines Corp.). Normality distribution will be tested with the Shapiro-Wilk test; data will be considered normal if the p value is less than 0.05. The central tendency and statistical dispersion of each parameter will be recorded as the mean and standard deviation (SD) for normal data and as the median and interquartile difference for nonparametric data. The coordinates of keratometric cylinders and the centroids will be calculated according to the Alpins method. Double-angle polar plots will be used to display the astigmatism analysis (Excel 2011 for Macintosh, Microsoft Corp.). The Student t test for paired samples and the Wilcoxon signed-rank test will be used for normal and nonparametric data, respectively, to compare the 2 related samples. A statistically significant difference will be defined as a p value less than 0.05. Any adverse event will be recorded.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Corneal Astigmatism

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Toric intraocular MX60T lens
Arm Type
Experimental
Arm Description
one eye will receive toric MX60T lens
Arm Title
Standard MX60 plus corneal incisions
Arm Type
Other
Arm Description
the other eye will receive standard MX60 lens with corneal incisions
Intervention Type
Device
Intervention Name(s)
Toric intraocular MX60T lens
Intervention Description
one eye will receive toric MX60T lens
Intervention Type
Other
Intervention Name(s)
Standard MX60 plus corneal incisions
Intervention Description
the other eye will receive standard MX60 lens with corneal incisions
Primary Outcome Measure Information:
Title
Astigmatism reduction effect of toric intraocular lens (IOL) versus non-toric IOL with limbal relaxing incisions.
Description
Astigmatism reduction will be evaluated with optical biometry, corneal topography
Time Frame
6 months and 12 months
Title
Astigmatism reduction effect of toric intraocular lens (IOL) versus non-toric IOL
Description
Astigmatism reduction will be evaluated with manifest refraction, autorefraction
Time Frame
6 months and 12 months
Secondary Outcome Measure Information:
Title
Unaided visual acuity after toric intraocular lens (IOL) versus non-toric IOL with limbal relaxing incisions.
Description
Measurement of uncorrected visual acuity, monocular and binocular, will be done using a back-lit EDTRS chart placed at 4m. Although these assessments appear to have different units of measurements, but all the measurements will be in the same units of measure.
Time Frame
6 months and 12 months
Title
Best-spectacle corrected visual acuity after toric intraocular lens (IOL) versus non-toric IOL with limbal relaxing incisions.
Description
Measurement of best-spectacle corrected visual acuity, monocular and binocular, will be done using a back-lit EDTRS chart placed at 4m.
Time Frame
6 months and 12 months
Title
Quality of Vision
Description
Quality of Vision will be evaluated with the QoV (Quality of Vision) questionnaire score. It is a validated, Rasch-adjusted questionnaire in which patients are asked to rate 10 dysphotopsia items illustrated by standard photographs, scoring each item (0, 1, 2, 3) in relation to how frequent, severe, and bothersome their symptoms are (30 items in total).
Time Frame
6 months and 12 months
Title
Visual disability
Description
Visual disability will be evaluated with the Catquest 9-SF cataract visual disability questionnaire. It is a Rasch-adjusted cataract visual disability questionnaire that asks patients to rate difficulty with a range of vision-related daily activities.
Time Frame
6 months and 12 months
Title
Overall satisfaction
Description
Overall satisfaction will be evaluated with vision rating questionnaire. It will be obtained by asking patients to rate whether they were very satisfied, satisfied, neither satisfied nor unsatisfied, unsatisfied, or very unsatisfied.
Time Frame
6 months and 12 months
Title
Dysphotopsia
Description
Dysphotopsia will be evaluated with the Dysphotopsia questionnaire. They are 4 questions regarding dysphotopsia symptoms: "Since your surgery, have you noticed any" halo, glare or dazzle, unwanted images, or shadows? Patients were asked to respond by indicating whether they had not experienced these symptoms at all ("none") or found them "barely noticeable," "annoying," or "debilitating."
Time Frame
6 months and 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Bilateral cataract. Age 21 and older. Written informed consent to sequential bilateral surgery and participation in the study. Preoperative pupil size greater than or equal to 5.0 mm in the study eye. IOL power as predicted by biometry ranging from 6.0 D to 30.0 D in both eyes. Regular corneal astigmatism according to Orbscan topography. Postoperative corneal astigmatism between 0.90 D and 1.40 D in both eyes, as predicted by the Bausch + Lomb Toric Calculator (https://envista.toriccalculator.com). Exclusion Criteria: Ocular comorbidity (corneal scars, amblyopia, retina, or optic nerve disease) that may reduce postoperative CDVA Reduced zonular or capsular stability (e.g. Marfan syndrome, previous eye trauma) Irregular corneal astigmatism on Orbscan topography
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Isaac John, PhD
Phone
0044 193 272 2901
Email
Isaac.John@nhs.net
First Name & Middle Initial & Last Name or Official Title & Degree
Freda Gomes, MSc
Phone
0044 193 272 6664
Email
Freda.Gomes@nhs.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vinod Gangwani, MBBS FRCS
Organizational Affiliation
Ashford and St. Peter's Hospitals NHS Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dr Isaac John
City
Chertsey
State/Province
Surrey
ZIP/Postal Code
KT16 0PZ
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Freda Gomes
Phone
01932723534
Email
freda.gomes@nhs.net
First Name & Middle Initial & Last Name & Degree
Vinod Gangwani

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Toric IOL vs Non-toric IOL With LRI for Corneal Astigmatism

We'll reach out to this number within 24 hrs